Table of Contents

company-logo

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.

Healios Dividend Announcement

• Healios does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Healios dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Healios Dividend History

Healios Dividend Yield

Healios current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Healios stock? Use our calculator to estimate your expected dividend yield:

Healios Financial Ratios

P/E ratio-3.33
PEG ratio-0.03
P/B ratio5.53
ROE-131.47%
Payout ratio0.00%
Current ratio1.39
Quick ratio1.39
Cash Ratio1.25

Healios Dividend FAQ

Does Healios stock pay dividends?
Healios does not currently pay dividends to its shareholders.
Has Healios ever paid a dividend?
No, Healios has no a history of paying dividends to its shareholders. Healios is not known for its dividend payments.
Why doesn't Healios pay dividends?
There are several potential reasons why Healios would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Healios ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Healios has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Healios a dividend aristocrat?
Healios is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Healios a dividend king?
Healios is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Healios a dividend stock?
No, Healios is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Healios stocks?
To buy Healios you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Healios stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.